Abstract
Tens of millions of surgical procedures are performed annually in the United States and the world over. A significant proportion of these procedures are associated with perioperative adverse cardiac events and these in turn, increase cardiovascular morbidity and mortality. Perioperative myocardial infarction, variably defined in the historical literature, may in fact occur in greater than 1 in 10 post-surgical patients by current definitions. Preoperative risk assessment may be carried out using a variety of validated risk prognostication models. While guideline-driven medical therapies form the foundation of risk reduction in patients undergoing noncardiac surgery, high-risk findings on non-invasive assessment may necessitate coronary angiography. Whereas coronary revascularization is widely accepted as the standard of care in preoperative patients with acute coronary syndromes or acute myocardial infarction, the practice of routine preoperative coronary revascularization for the purpose of cardiac risk reduction, is neither supported by the available trial data nor endorsed by the U.S. and European clinical practice guidelines, even in patients undergoing high risk noncardiac surgeries. Despite this, contemporary registry data bears out the wide usage of preoperative coronary revascularization. Small European studies have hinted at benefit associated with a strategy of routine coronary angiography and when necessary, percutaneous revascularization, in high-risk patients pending vascular operations. However these reports have yet to be confirmed in large-scale, randomized, multicenter trials. Unanswered questions remain regarding the optimal duration of dual antiplatelet therapy and timing of surgery in patients who have had prior percutaneous coronary revascularization.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Fleisher LA, Fleischmann KE, Auerbach AD, et al. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;64(22):e77–137.
Boersma E, Kertai MD, Schouten O, et al. Perioperative cardiovascular mortality in noncardiac surgery: validation of the Lee cardiac risk index. Am J Med. 2005;118(10):1134–41.
Devereaux PJ, Yang H, Yusuf S, et al.; POISE Study Group. Effects of extended-release metoprolol succinate in patients undergoing noncardiac surgery (POISE trial): a randomised controlled trial. Lancet. 2008;371:1839–47.
Poldermans D, Bax JJ, Boersma E, et al.; Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Noncardiac Surgery; European Society of Cardiology (ESC). Guidelines for preoperative cardiac risk assessment and perioperative cardiac management in noncardiac surgery. Eur Heart J. 2009;(22):2769–812.
Devereaux PJ, Chan MT, Alonso-Coello P, et al.; The Vascular Events In Noncardiac Surgery Patients Cohort Evaluation (VISION) Study Investigators. Association between postoperative troponin levels and 30-day mortality among patients undergoing noncardiac surgery. JAMA. 2012;307(21):2295–304.
Schulman-Marcus J, Pashun RA, Feldman DN, et al. Coronary angiography and revascularization prior to noncardiac surgery. Curr Treat Options Cardiovasc Med. 2016;18(1):3.
Fleisher LA, Eagle KA. Lowering cardiac risk in noncardiac surgery. N Engl J Med. 2001;345:1677–82.
Ehlers R, Felbinger TW, Eltzschig HK. Comment on: clinical practice. Lowering cardiac risk in noncardiac surgery. N Engl J Med. 2002;346(14):1096–7.
Kristensen SD, Knuuti J, Saraste A, et al. 2014 ESC/ESA guidelines on noncardiac surgery: cardiovascular assessment and management: the Joint Task Force on noncardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). Eur Heart J. 2014;35(35):2383–431.
Poldermans D, Bax JJ, Schouten O, et al. Should major vascular surgery be delayed because of preoperative cardiac testing in intermediate-risk patients receiving beta-blocker therapy with tight heart rate control? J Am Coll Cardiol. 2006;48(5):964–9. Epub 2006 Aug 17.
Hertzer NR, Bever EG, Young JR, et al. Coronary artery disease in peripheral vascular patients. A classification of 1000 coronary angiograms and results of surgical management. Ann Surg. 1984;199(2):223–33.
Gupta PK, Gupta H, Sundaram A, et al. Development and validation of a risk calculator for prediction of cardiac risk after surgery. Circulation. 2011;124(4):381–7.
Lee TH, Marcantonio ER, Mangione CM, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation. 1999;100(10):1043–9.
Ford MK, Beattie WS, Wijeysundera DN. Systematic review: prediction of perioperative cardiac complications and mortality by the revised cardiac risk index. Ann Intern Med. 2010;152(1):26–35.
Bertges DJ, Goodney PP, Zhao Y, et al. The Vascular Study Group of New England Cardiac Risk Index (VSG-CRI) predicts cardiac complications more accurately than the Revised Cardiac Risk Index in vascular surgery patients. J Vasc Surg. 2010;52(3):674–83.
Hertzer NR, Young JR, Beven EG, et al. Late results of coronary bypass in patients presenting with lower extremity ischemia: the Cleveland Clinic Study. Ann Vasc Surg. 1987;1(4):411–9.
Eagle KA, Rihal CS, Mickel MC, et al. Cardiac risk of noncardiac surgery: influence of coronary disease and type of surgery in 3368 operations. CASS Investigators and University of Michigan Heart Care Program. Coronary Artery Surgery Study. Circulation. 1997;96(6):1882–7.
McFalls EO, Ward HB, Moritz TE, et al. Coronary-artery revascularization before elective major vascular surgery. N Engl J Med. 2004;351(27):2795–804.
Garcia S, Moritz TE, Ward HB, et al. Usefulness of revascularization of patients with multivessel coronary artery disease before elective vascular surgery for abdominal aortic and peripheral occlusive disease. Am J Cardiol. 2008;102(7):809–13.
Poldermans D, Schouten O, Vidakovic R, et al.; Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echo (DECREASE) Study Group. A clinical randomized trial to evaluate the safety of a noninvasive approach in high-risk patients undergoing major vascular surgery: the DECREASE-V Pilot Study. J Am Coll Cardiol. 2007;49(17):1763–9.
Schouten O, van Kuijk JP, Flu WJ, et al. Long-term outcome of prophylactic coronary revascularization in cardiac high-risk patients undergoing major vascular surgery (from the randomized DECREASE-V Pilot Study). Am J Cardiol. 2009;103(7):897–901.
Monaco M, Stassano P, Di Tommaso L, et al. Systematic strategy of prophylactic coronary angiography improves long-term outcome after major vascular surgery in medium- to high-risk patients: a prospective, randomized study. J Am Coll Cardiol. 2009;54(11):989–96.
Rott D. Prophylactic coronary angiography improves outcome after major vascular surgery. Comment on: Systematic strategy of prophylactic coronary angiography improves long-term outcome after major vascular surgery in medium- to high-risk patients: a prospective, randomized study. J Am Coll Cardiol. 2010;55(13):1396.
Kaluski E. Prophylactic preoperative coronary revascularization: Do we have the data? Comment on: systematic strategy of prophylactic coronary angiography improves long-term outcome after major vascular surgery in medium- to high-risk patients: a prospective, randomized study. J Am Coll Cardiol. 2010;55(13):1396–7.
Pullatt RC, Silverman DI, Heller GV. Are long-term outcomes of medium- to high-risk patients undergoing vascular surgery affected by the ischemia evaluation strategy? Comment on: systematic strategy of prophylactic coronary angiography improves long-term outcome after major vascular surgery in medium- to high-risk patients: a prospective, randomized study. J Am Coll Cardiol. 2010;55(13):1397.
Illuminati G, Schneider F, Greco C, et al. Long-term results of a randomized controlled trial analyzing the role of systematic preoperative coronary angiography before elective carotid endarterectomy in patients with asymptomatic coronary artery disease. Eur J Vasc Endovasc Surg. 2015;49(4):366–74.
Ramanath VS, Eagle KA, Nienaber CA, et al. The role of preoperative coronary angiography in the setting of type A acute aortic dissection: insights from the International Registry of Acute Aortic Dissection. Am Heart J. 2011;161(4):790–6.
Schulman-Marcus J, Feldman DN, Rao SV, et al. Characteristics of patients undergoing cardiac catheterization before noncardiac surgery: a report from the National Cardiovascular Data Registry CathPCI Registry. JAMA Intern Med. 2016;176(5):611–8.
Brown DL, Redberg RF. Continuing use of prophylactic percutaneous coronary intervention in patients with stable coronary artery disease despite evidence of no benefit. JAMA Intern Med. 2016;176(5):597–8.
Sharma A, Khan JS, Bainey KR. Preoperative stress tests – superfluous investigations resulting in excessive treatment delay: a teachable moment. JAMA Intern Med. 2015;175(10):1610–1.
Wald DS Morris JK, Wald NJ, et al. for the PRAMI Investigators. Randomized trial of preventive angioplasty in myocardial infarction. N Engl J Med. 2013;369:1115–23.
Gershlick AH, Khan JN, Kelly DJ, et al. Randomized trial of complete versus lesion-only revascularization in patients undergoing primary percutaneous coronary intervention for STEMI and multivessel disease. The CvLPRIT Trial. J Am Coll Cardiol. 2015;65(10):963–72.
Hawn MT, Graham LA, Richman JS, et al. Risk of major adverse cardiac events following noncardiac surgery in patients with coronary stents. JAMA. 2013;310(14):1462–72.
Mahmoud KD, Sanon S, Habermann EB, et al. Perioperative cardiovascular risk of prior coronary stent implantation among patients undergoing noncardiac surgery. J Am Coll Cardiol. 2016;67(9):1038–49.
Wakabayashi Y, Wada H, Sakakura K, et al. Major adverse cardiac and bleeding events associated with noncardiac surgery in coronary artery disease patients with or without prior percutaneous coronary intervention. J Cardiol. 2015;66(4):341–6.
Levine GN, Bates ER, Bittl JA, et al. 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2016;68(10):1082–115.
Patel AY, Eagle KA, Vaishnava P. Cardiac risk of noncardiac surgery. J Am Coll Cardiol. 2015;66(19):2140–8.
Devereaux PJ, Goldman L, Cook DJ, et al. Perioperative cardiac events in patients undergoing noncardiac surgery: a review of the magnitude of the problem, the pathophysiology of the events and methods to estimate and communicate risk. CMAJ. 2005;173(6):627–34.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Kalathiya, R., Shah, A., Nathan, S. (2017). In Patients Undergoing Vascular Surgery, Does Preoperative Coronary Revascularization Reduce the Risk of Myocardial Infarction and Death?. In: Skelly, C., Milner, R. (eds) Difficult Decisions in Vascular Surgery. Difficult Decisions in Surgery: An Evidence-Based Approach. Springer, Cham. https://doi.org/10.1007/978-3-319-33293-2_42
Download citation
DOI: https://doi.org/10.1007/978-3-319-33293-2_42
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-33291-8
Online ISBN: 978-3-319-33293-2
eBook Packages: MedicineMedicine (R0)